Abstract

A novel class of HCV NS5B RNA dependent RNA polymerase inhibitors containing 3,4-dihydro-1 H-[1]-benzothieno[2,3- c]pyran and 3,4-dihydro-1 H-pyrano[3,4- b]benzofuran scaffolds were designed and synthesized. Optimization of the alkyl substituent in the pyran ring showed preference for an n-propyl group, while 5,8-disubstitution pattern is preferred for the aromatic region. Analog 19 displayed potent activity with an IC 50 of 50 nM against HCV NS5B enzyme and was selective over a panel of polymerases.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.